When will Rocket Lab's Iridium deal close?

Updated from live prices and SEC filings

Rocket Lab targets mid-2027. Iridium's vote and US antitrust clearance are done; FCC consent and some foreign approvals remain. Our sums: with Rocket Lab below the $67.50 collar floor, the $54 headline is worth $50.54 per Iridium share at 9 November closes, 12.1% above Iridium's $45.08.

The short answer

Rocket Lab and Iridium expect the deal to complete by mid-2027. Rocket Lab agreed on 29 June 2026 to buy Iridium for an enterprise value of about $8.0B, paying $27.00 in cash plus Rocket Lab shares for each Iridium share.

Three of the hurdles are cleared: the US antitrust (HSR) waiting period expired on 12 August, the share registration was declared effective on 26 August, and Iridium shareholders approved the deal on 24 September with about 99.6% of votes cast in favour. Rocket Lab's Q3 10-Q lists what is left: consent from the FCC, certain foreign regulatory approvals and other customary conditions. Rocket Lab also says the deal is now fully funded. The merger agreement's end date is 28 June 2027, which can be extended to 28 September and then 28 December 2027 if regulatory approvals are still pending.

Orbit Alpha view: the $54 headline is worth $50.54 today

The deal was announced as worth $54.00 per Iridium share: $27.00 in cash plus $27.00 in Rocket Lab stock. But the stock half only holds at $27.00 while Rocket Lab's share price is between $67.50 and $112.50. Below $67.50 the exchange ratio is fixed at 0.4000 Rocket Lab shares, so the stock half shrinks as Rocket Lab falls. Rocket Lab closed at $58.86 on 9 November, well under the floor, so on our sums the offer was worth $50.54 per Iridium share: $27.00 plus 0.4 x $58.86 = $23.54.

Rocket Lab share priceExchange ratioValue per Iridium shareNew Rocket Lab sharesDilution
$45.200.4000$45.08 (Iridium's close)42.4M6.7%
$50.000.4000$47.0042.4M6.7%
$58.86 (9 Nov close)0.4000$50.5442.4M6.7%
$67.50 (collar floor)0.4000$54.0042.4M6.7%
$90.000.3000$54.0031.8M5.0%
$112.50 (collar cap)0.2400$54.0025.4M4.0%

How we got it: our calculations use the collar terms in the merger agreement, the 105,981,552 Iridium shares outstanding at the record date (equity awards excluded) and Rocket Lab's 632.0M shares outstanding on 4 November. The final ratio is set by Rocket Lab's 10-day average price ending two trading days before completion.

Three points follow. First, Iridium closed at $45.08 on 9 November, $5.46 or 12.1% below the $50.54 the deal paid on that day's prices. Put another way, Iridium's price would equal the deal value only if Rocket Lab were at $45.20, so the market is pricing in time to completion, the remaining approvals and Rocket Lab's own share price swings. Second, below the floor the dilution is capped: Rocket Lab issues at most about 42.4M shares, 6.7% of its share count, however far its price falls. The risk of a lower price lands on Iridium holders, not on Rocket Lab's. Third, the cash is in hand. The cash portion comes to about $2.86B on our sums, against $4.70B of cash and marketable securities at 30 September, after $3.91B of gross at-the-market share sales in the first nine months of 2026. Rocket Lab terminated its $3.6B bridge loan commitment on 15 September without drawing on it, booking a $27.3M loss on extinguishment.

MeasureFigureSource or working
Cash portion of the dealAbout $2.86BOur calculation: $27.00 x 105,981,552 shares
Cash and marketable securities, 30 Sept 2026$4.70BOur sum from the 10-Q: $4,447.7M cash + $256.2M securities
Left after paying the cash portionAbout $1.84BOur calculation, before deal costs
Iridium term loans that stay in placeAbout $1.78BRocket Lab Q3 10-Q, guaranteed by Rocket Lab USA
Rocket Lab market value, 9 Nov closeAbout $37.2BOur calculation: $58.86 x 632.0M shares
Iridium Q3 2026 revenue$245.7MIridium Q3 results
Rocket Lab Q3 2026 revenue$267.8MRocket Lab Q3 results

The last two rows show why the deal matters. On Q3 figures Iridium would nearly double Rocket Lab's quarterly revenue, to about $513.5M on our simple sum. Iridium earned $135.6M of operational EBITDA in Q3, while Rocket Lab posted an adjusted EBITDA loss of $18.0M. The two measures are defined differently, so the sum is only a rough guide, but it suggests the combined group would be EBITDA-positive well before Neutron flies.

Read next

What the FCC is weighing

The FCC must approve the transfer of Iridium's licences. Rocket Lab and Iridium told the FCC in a filing posted on 2 November that the deal will not harm competition or the public interest, and they have asked for quick approval, pointing to the FCC's approval of Amazon's purchase of Globalstar (see our analysis of that deal).

  • Globalstar: says it does not oppose the deal, but asked the FCC to look at Rocket Lab's role as its satellite supplier. Rocket Lab says eight Globalstar satellite platforms it built have launched and are operating, and Globalstar argues that relationship could give Rocket Lab both the incentive and the means to favour Iridium.
  • SpaceX: has raised satellite ground station coordination issues. The companies say SpaceX does not oppose the deal.
  • Ligado: concerns about interference with its planned operations. Rocket Lab and Iridium argue that both the SpaceX and Ligado issues predate the deal and belong in separate proceedings.

Replies in the FCC pleading cycle were due on 9 November, per Stocktwits. The FCC has not set a decision date.

What it means for other covered stocks

Globalstar is both a Rocket Lab customer and an Iridium rival in satellite phones and IoT, and it is itself being bought by Amazon. Its filing is about protecting the supply of its next satellites, so watch whether the FCC attaches conditions on supplier conduct. SpaceX competes with Rocket Lab in launch and, through Starlink, with Iridium in satellite connectivity. For Rocket Lab, Iridium adds a satellite network with recurring service revenue next to its launch and spacecraft businesses.

Dates and thresholds to watch

  • The FCC decision, and whether it comes with conditions. The FCC is the main approval left.
  • Foreign regulatory approvals, which Rocket Lab has not itemised.
  • $67.50: if Rocket Lab's 10-day average price is above this at completion, the stock half is worth $27.00 and fewer shares are issued. Below it, 0.4000 shares are issued and the value falls.
  • 28 June 2027: the merger agreement's end date, which can be extended to 28 September and 28 December 2027 for regulatory approvals. A $223.6M termination fee is payable by Iridium to Rocket Lab in specified circumstances.
  • Iridium's dividend: its board plans to raise the quarterly dividend to $0.16 a share from the Q4 2026 payment, which Iridium holders collect while they wait.

For the latest quarter see Rocket Lab's Q3 2026 results and Globalstar's Q3 2026 results. For Neutron's timing see When is Rocket Lab's Neutron first launch?, and for balance sheets across the sector the cash runway guide.

Questions and answers

Is the Rocket Lab Iridium deal approved?

Not fully. Iridium shareholders approved it on 24 September 2026 and the US antitrust waiting period expired on 12 August. FCC consent and certain foreign approvals are still needed.

What do Iridium shareholders get from Rocket Lab?

$27.00 in cash plus Rocket Lab shares for each Iridium share. The share ratio is 0.4000 if Rocket Lab's average price is at or below $67.50, $27.00 divided by the price between $67.50 and $112.50, and 0.2400 at or above $112.50.

Is the deal worth $54 a share?

Only if Rocket Lab's price is $67.50 or higher. At the 9 November close of $58.86 it was worth $50.54 per Iridium share on our sums.

How is Rocket Lab paying for Iridium?

With cash raised mainly through at-the-market share sales. It ended September with $4.70B of cash and marketable securities against a cash portion of about $2.86B on our sums, and it cancelled its $3.6B bridge loan commitment undrawn.

More

Sources

Published 10 Nov 2026. Orbit Alpha is information, not investment advice.

Orbit Alpha may earn a commission from some links on this page, at no extra cost to you.

Orbit Alpha is a free space stocks dashboard and weekly newsletter covering 30 listed space companies, with live prices, launches, earnings dates, SEC filings, insider trades and US government contracts in one place.